Delivery Order SPE2DB20D3101-SPE2DB23FQTT5
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,861.68 firm fixed-price contract covers the supply of Oseltamivir Phosphate 75 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,378.24, is for the procurement of Oseltamivir Phosphate 75 mg capsules. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,017.05 delivery order contract is for the supply of 4,567,584,763 units of the drug Oseltamivir Phosphate 30 mg capsules. The contract has a period of performance through March 17, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,198,891 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The $3,189.12 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense responsible for providing medical supplies to military treatment facilities and other federal healthcare programs. The contract has no...
- This federal contract award is a delivery order valued at $1,494.60 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,563,471,961 units of the drug Oseltamivir Phosphate 75 mg capsules, an antiviral medication used to treat and prevent influenza. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is a firm fixed-price contract with no set-aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,558,583 units of Oseltamivir Phosphate 75 mg capsules, with a ceiling value of $1,139.83. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,109.24 firm fixed-price contract is for the delivery of Oseltamivir Phosphate 75 mg capsules, which are used to treat influenza. The award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This is a $1,541.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Oseltamivir Phosphate 75mg capsules. The award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the sole awardee. This IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support...
- This federal contract award, valued at $1,238.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Oseltamivir Phosphate 75 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and runs through December 2025. This single-award IDC serves as the primary vehicle...
- This federal contract award, valued at $1,272.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,646,936 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules, with an ultimate completion date of October 31, 2023. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FQTT5Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $1,853.16 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Oseltamivir Phosphate 75 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/2/22 |